This company manufactures medical electrodes designed for reliable performance in long-term medical applications. Their electrodes aim to provide consistent and dependable results for various medical uses.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional gel-based electrodes used in long-term medical monitoring, such as Holter ECG, often suffer from signal degradation due to gel drying out, leading to inaccurate readings and the need for frequent electrode replacements. This can cause discomfort for patients and increase the risk of errors due to improper reapplication.
Solution
Nahtlos provides a line of advanced textile-based medical electrodes that offer a superior alternative to traditional gel electrodes for long-term monitoring applications. Their Duratrode and Durastrip electrodes utilize conductive textiles and membrane technologies, eliminating the need for gels and providing consistent, high-quality signal acquisition for up to 10 days. This design enhances patient comfort by removing the need for frequent changes, reduces the risk of signal failure due to electrode drying or misplacement, and offers a cost-effective solution for extended diagnostic monitoring. The electrodes are designed for applications such as Holter ECG and compatibility with wearable sensors like Movesense.
Target Audience
The primary target audience includes medical care providers, hospitals, and remote patient monitoring services requiring reliable, long-term electrodes for diagnostics such as Holter ECG and other physiological measurements.
Features
- Gel-free design utilizing conductive textiles and membrane technology
- Consistent signal quality maintained for up to 10 days of continuous use
- Enhanced patient comfort due to reduced need for electrode replacements
- Cost-effective solution for long-term cardiac and physiological monitoring
- Durastrip electrodes are compatible with Movesense wearable sensors
- Available in Duratrode (pack of 5) and Durastrip (single electrode) formats